guanabenz has been researched along with Demyelinating Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Thompson, KK; Tsirka, SE | 1 |
Clayton, BLL; Popko, B | 1 |
1 review(s) available for guanabenz and Demyelinating Diseases
Article | Year |
---|---|
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Demyelinating Diseases; Endoplasmic Reticulum Stress; Guanabenz; Humans; Neuroglia; Unfolded Protein Response | 2016 |
1 other study(ies) available for guanabenz and Demyelinating Diseases
Article | Year |
---|---|
Guanabenz modulates microglia and macrophages during demyelination.
Topics: Animals; Antihypertensive Agents; B7-2 Antigen; Central Nervous System; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Inflammation; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neurons; Nitric Oxide Synthase Type II; Oligodendroglia; Patient Safety; Phagocytosis; Remyelination | 2020 |